| pubmed-article:20367522 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20367522 | lifeskim:mentions | umls-concept:C0000820 | lld:lifeskim |
| pubmed-article:20367522 | lifeskim:mentions | umls-concept:C0026140 | lld:lifeskim |
| pubmed-article:20367522 | lifeskim:mentions | umls-concept:C0026088 | lld:lifeskim |
| pubmed-article:20367522 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:20367522 | lifeskim:mentions | umls-concept:C2828358 | lld:lifeskim |
| pubmed-article:20367522 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:20367522 | pubmed:dateCreated | 2010-4-28 | lld:pubmed |
| pubmed-article:20367522 | pubmed:abstractText | Medical abortion using mifepristone followed by misoprostol is increasingly used for termination of an unwanted pregnancy. Consequently, an increasing number of women undergo medical abortion while still breastfeeding from a previous pregnancy. But there are no data on mifepristone use during lactation. We studied the levels of mifepristone in breast milk collected from women undergoing medical abortion. DESIGN AND SAMPLES: Samples of milk were collected from 12 women during the first 7 days after intake of either 200 mg (n = 2) or 600 mg (n = 10) of mifepristone. In addition, serum samples were collected on day 3 (n = 4). Main outcome measures. The levels of mifepristone, quantified using radioimmunoassay. | lld:pubmed |
| pubmed-article:20367522 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20367522 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20367522 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20367522 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20367522 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20367522 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20367522 | pubmed:month | May | lld:pubmed |
| pubmed-article:20367522 | pubmed:issn | 1600-0412 | lld:pubmed |
| pubmed-article:20367522 | pubmed:author | pubmed-author:FialaChristia... | lld:pubmed |
| pubmed-article:20367522 | pubmed:author | pubmed-author:HeikinheimoOs... | lld:pubmed |
| pubmed-article:20367522 | pubmed:author | pubmed-author:Gemzell-Danie... | lld:pubmed |
| pubmed-article:20367522 | pubmed:author | pubmed-author:HämäläinenJon... | lld:pubmed |
| pubmed-article:20367522 | pubmed:author | pubmed-author:SäävIngridI | lld:pubmed |
| pubmed-article:20367522 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20367522 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:20367522 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20367522 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20367522 | pubmed:pagination | 618-22 | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:meshHeading | pubmed-meshheading:20367522... | lld:pubmed |
| pubmed-article:20367522 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20367522 | pubmed:articleTitle | Medical abortion in lactating women--low levels of mifepristone in breast milk. | lld:pubmed |
| pubmed-article:20367522 | pubmed:affiliation | Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:20367522 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20367522 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20367522 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
